Rheumnow

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 423:37:43
  • More information

Informações:

Synopsis

Podcast by Dr. Cush

Episodes

  • ACR24 - Day4b

    20/11/2024 Duration: 15min

    ANCA Vasculitis "Eye": Can rituximab help?:Dr. Janet Pope Apremilast in PsA: Results from Mosaic Trial:Dr. Guillermo Valenzuela  Implantable Vagus Nerve Stimulator for RA:Dr. Guillermo Valenzuela  Treat-to-Target Improves Fertility in Women with RA:Dr. Richard Conway 

  • RheumNow Day 4 Recap ACR Convergence 2024 Highlights

    20/11/2024 Duration: 28min

    Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

  • ACR24 - Day4a

    19/11/2024 Duration: 53min

    ACR 24: What I learned in Sjogren's, Takayasu's and CAR-T:Dr. Janet Pope Anti IL-17 on Entheseal Biopsy in PsA:Dr. Eric Dein  axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure:Dr. Brian Jaros Can We Make Clinical Trials Better?:Dr. Janet Pope Cumulative Steroid Use and Cardiovascular Events:Dr. Mrinalini Dey  IL 6 Inhibitors, Frailty and Polymyalgia Rheumatica:Drs. Trish Harkins and Sebastian Sattui IVIG Treatment in Immune-mediated Necrotizing Myopathy:Drs. Caoilfhionn Connolly interviews Dr. Asim Mohamed  Machine Learning for Predicting Flares in axSpA:Dr. Sheila Reyes So really, are JAKs Safe?:Dr. Janet Pope Tackling the Workforce Crisis: A shared dilemma:Drs. Mrinalini Dey,  Louise Pollard and Bharat Kumar The 2024 ACR Guidelines for Lupus Nephritis:Dr. Sheila Reyes  The Real Value of JAKi is Beyond RA:Dr. David Liew  Vaccine Responses:The DMARD Counts:Dr. David Liew

  • RheumNow Day 3 Recap ACR Convergence 2024 Highlights

    19/11/2024 Duration: 26min

    Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

  • ACR24 -Day3b

    19/11/2024 Duration: 01h03min

    Best Things I Saw Today in PsA:Dr. Catherine Bakewell  Do TNFis and JAKis Prevent Cancer!?:Dr. Richard Conway Efficacy and Safety of Nipocalimab for Sjogren's Syndrome:Dr. Mike Putman Evaluating ANA Patterns and Titers with AI:Dr. Bella Mehta Improvements in Pain and Fatigue in Bimekizumab:Dr. Philip Mease  Long Term Follow up from APIPPRA:Dr. Antoni Chan talks with Dr. Andrew Cope Race Neutral PFTs in Scleroderma Improves Equity:Dr. Caoilfhionn Connolly talks with Dr. Kamini Kuchinad  Summary of JAKi Studies:Dr. Peter Nash The Psoriatic March: PsA before PsO:DR. Antoni Chan Use of AI in Hand Ultrasound Scoring:Dr. Bella Mehta  What is MCTD? The Great Debate:Drs. Caoilfhionn Connolly & Lisa Christopher-Stine What's The State of Biosimilars?:Drs. Eric Dein and Jonathan Kay Pred Softly: Steroids:Dr. Jiha Lee talks with Dr. Beth Wallace

  • ACR24 - Day3a

    18/11/2024 Duration: 34min

    Control RA, Build Stronger Bones:Dr. Jiha Lee talks with Dr. Rachel Elam  Hold or continue JAKi and IL-17 when receiving COVID boosters?:Dr. Bella Mehta Long-term Safety Profile of Bimekizumab in axSpA and PsA:Dr. Philip Mease Navigating Rheumatology Care in Humanitarian Crisis Settings:Dr. Antoni Chan talks with Dr. Martha Dhzhus RA Roundup: Is LDA Inappropriate? What about Statins for JAKs?:Dr. Eric Dein  Sex Differences in Psoriatic Arthritis:Dr. Catherine Bakewell Single v Double Lung Transplants for Disease-related ILD:Dr. Eric Dein talks with Dr. Harry Hurley Sonelokimab in PsA: Phase 2 Data:Dr. Philip Mease Treating SpA:Dr. Marina Magrey

  • ACR24 - Day2d

    18/11/2024 Duration: 18min

    Assessment of axSpA:Dr. Antoni Chan  Defining Difficult to Manage axSpA:Dr. Lihi  DISH in SpA:Dr. Sheila Reyes Generative AI in Rheumatology: The Good, The Bad, The Ugly:Dr. Akhil Sood  Native Americans with RA Die Young:Dr. Eric Dein Precision Immunotherapy in Axial SpA:Dr. Marina Magrey  When, What and How Long to Treat GCA & PMR:Dr. Janet Pope 

  • ACR24 - Day2c

    18/11/2024 Duration: 29min

    A Fibroblast Renaissance:Dr. Andrea Fava A useful urinary biomarker for lupus nephritis:Dr. Andrea Fava ACR Advocacy Update:Dr. Eric Dein talks with Dr. Christina Downey, ACR Government Affairs Committee, and Dr. Kaitlyn Brittan, RheumPAC Carotid Doppler Ultrasound Screening in Axial SpA:Dr. Trish Harkins discussed with Dr. Barry O'Shea  Enhanced Detection of Myocarditis in Idiopathic Inflammatory  Myopathies:Dr. Caoilfhionn Connolly talks with Dr. Julie Paik PsA: Impact of Sex:Dr. Arthur Kavanaugh Rethinking Lupus Care: Early Biologics, Less Steroids:Dr. Akhil Treatment Considerations for RA-ILD:Dr. Jeff Sparks with Dr. Scott Matson

  • ACR24 Daily Recap Day2

    18/11/2024 Duration: 40min

    Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

  • ACR24 - Day2b

    18/11/2024 Duration: 52min

    JAKi Studies at ACR:Dr. Peter Nash Palliative Care in Rheumatology:Dr. Jiha Lee talks with Dr. Shannon Herndon Estimating Inflammation, Damage and Patient Distress:Dr. Jack Cush talks with Dr. Ted Pincus Methotrexate and the Gut Microbiome:Dr. Jonathan Kay talks with Dr. Rebecca Blank Poly-treatment of Polymyalgia Rheumatica?:Dr. Janet Pope Predicting Flares in Rheumatoid Arthritis:Dr. Jonathan Kay interviews Dr. John Isaacs  "Changing Mindsets about Methotrexate Side Effects":Dr. Mrinalini Dey Biologic Monotherapy vs Combination with cDMARDs in PsA:Dr. Adela Castro Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis:Dr. Mike Putman ANA+ and no Autoimmune Disease? Check the liver:Dr. Janet Pope SELECTing the right patients: upadacitinib in GCA:Dr. Brian Jaros Neuropsychiatric Lupus: The Forgotten Symptoms:Dr. Mrinalini Dey talks with Dr. Chris Wincup

  • ACR24 - Day2a

    17/11/2024 Duration: 29min

    Bimekizumab in PsA Showed Sustained Reductions in Disease Impact:Dr. Eric Dein talks with Dr. Ana-Marie Orbai  CAR-T Therapy and Lupus:Dr. Akhil Sood talks with Dr. Chris Wincup Cycling vs Switching after TNFi Failure in axSpA:Dr. Lihi Eder Difficult to manage AxSpA:Dr. Sheila Reyes talks with Dr. Denis Poddubnyy  Gender Differences in AxSpA:Dr. Adela Castro Metabolic Dysregulation and RA Interstitial Lung Disease:Dr. Mrinalini Dey  PsA Ultrasound Updates:Dr. Catherine Bakewell and Dr. Lihi Eder  SELECT-GCA: Efficacy and Safety of Upadacitinib:Dr. Richard Conway

  • RheumNow Day 1 Recap ACR Convergence 2024 Highlights

    17/11/2024 Duration: 38min

    Catch the latest insights from the ACR Annual Meeting, where leading experts share groundbreaking research and clinical advances in rheumatology. Don’t miss our live coverage of key takeaways and trends shaping the future of patient care. Join us live and stay at the forefront of rheumatology!

  • ACR24 - Day1c

    17/11/2024 Duration: 01h31s

    Aging Gracefully in Managing Rheumatic Diseases:Dr. Mrinalini Dey interviews Dr. Elena Myasoedova Apremilast Benefits and Risks in PsA:Dr. Akhil Sood  Assessing ASAS Criteria: CLASSIC Study Results:Dr. Adela Castro Assessment and management of axSpA:Dr. Antoni Chan Disease Activity in RA-ILD:Dr. Richard Conway Finding the Right Combination Therapy in RA:Dr. Jonathan Kay interviews Dr. Ernest Choy Highlights in axSpA:Dr. Marina Magrey Hot Topics in axSpA:Dr. Marina Magrey Proposed ACR Guidance for Use of MSUS in Psoriatic Arthritis:Dr.  Antoni Chan interviews Dr. Catherine Bakewell PsA Potpourri:Dr. Arthur Kavanaugh RA Treatment Adherence: Is decision making really shared?:Dr. Jonathan  Kay interviews Dr. Cécile Gaujoux-Viala RA: One JAK to Rule Them All?:Dr. Brian Jaros What is a Positive MRI in Spondyloarthritis?:Dr. Sheila Reyes interviews Dr. Walter Maksymowych  

  • ACR24 - Day1b

    17/11/2024 Duration: 15min

    JAK-pot! How fast do DMARDs work?:Dr. Mike Putman and Dr. Kim Lauper Paraoxonase-1: Possible Biomarker for Progression to RA:Dr. Jonathan Kay Potential Impact of Weight Loss Drugs in Rheumatic Diseases:Dr. Arthur Kavanaugh PREDICT-SpA: Evaluating the influence of gender on disease assessment tools:Dr. Sheila Reyes SELECT-GCA: Upadacitinib in Giant Cell Arteritis:Dr. Mike Putman Too Many CAR-Ts for Horses?:Dr. Pope Transplant-free Survival Predictors in Idiopathic Inflammatory Myopathies-ILD:Dr. Gaby Martinez

  • ACR2024 - Day1a

    16/11/2024 Duration: 28min

    A New ACR:Dr. Cush Are we under-monitoring in scleroderma ILD?:Dr. Janet Pope Cancer Survival in RA:Dr. Eric Dein interviews Joshua Hsieh Continuing or Stopping Low Dose Glucocorticoids in GPA:Dr. Mike Putman  COVID Associated Immune Disease:Dr. Len Calabrese How to Master ACR Meetings:Dr. Cush

  • ACR 2024 Preview Podcast (11.15.2024)

    15/11/2024 Duration: 22min

    ACR 2024 starts tomorrow; here are a few previews of Abstracts to be presented. Along with my recommendations of sessions you don’t want to miss.  

  • Dr. Quotes (11.8.2024)

    08/11/2024 Duration: 23min

    Dr. Jack Cush reviews the news and journal reports from this past week from RheumNow.com

  • Minimizing Steroids in Lupus Sponsored by AstraZeneca Medical Affairs Nov 01, 2024

    04/11/2024 Duration: 24min

    Minimizing steroid use in patients with SLE. Learn more about when, why, and how to taper steroids and listen to experts, Dr Michelle Petri and Dr Leanna Wise, discuss key data and their clinical perspectives on these topics. 

  • Happy Diwali (11.1.2024)

    01/11/2024 Duration: 24min

    Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

  • Blue Collar Arthritis (10.25.2024)

    25/10/2024 Duration: 25min

    Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com Register now for RheumNow.live 2025

page 6 from 50